HYPERTENSION,ESSENTIAL
Clinical trials for HYPERTENSION,ESSENTIAL explained in plain language.
Never miss a new study
Get alerted when new HYPERTENSION,ESSENTIAL trials appear
Sign up with your email to follow new studies for HYPERTENSION,ESSENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can new pills tame high blood pressure?
Disease control CompletedThis clinical trial is testing whether two experimental oral medications, AD-224A and AD-224B, can safely lower blood pressure in people with essential hypertension (high blood pressure with no known cause). About 254 participants will take one of the drugs or a placebo once dail…
Matched conditions: HYPERTENSION,ESSENTIAL
Phase: PHASE3 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can cooking classes and exercise outperform medically tailored groceries for heart and kidney health?
Disease control CompletedThis study tests whether a 3-month community program combining nutrition education, cooking classes, and exercise can improve health outcomes for people with Cardiovascular Kidney Metabolic (CKM) syndrome—a cluster of conditions including diabetes, high blood pressure, high chole…
Matched conditions: HYPERTENSION,ESSENTIAL
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Pacemaker tweak may quietly lower blood pressure without extra pills
Disease control CompletedThis trial tests a special pacemaker called the BackBeat Moderato that can adjust its pacing to help control high blood pressure. Researchers will turn the device on and off for short periods in 28 people who already have the pacemaker implanted, measuring how their blood pressur…
Matched conditions: HYPERTENSION,ESSENTIAL
Phase: PHASE1, PHASE2 • Sponsor: BackBeat Medical Inc • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New injection for high blood pressure enters first human safety study
Disease control CompletedThis early-phase trial tested a single dose of SGB-3908, an experimental injectable drug, in 40 healthy volunteers and people with mild high blood pressure. The main goal was to check safety and how the body processes the drug. Researchers also looked at changes in a blood protei…
Matched conditions: HYPERTENSION,ESSENTIAL
Phase: PHASE1 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC